TurboPower + DCB Treatment of Femoropopliteal De Novo/ Restenotic and In-Stent Restenosis Lesions

Completed

Conditions studied: Peripheral Arterial Disease

In brief

A retrospective study to evaluate Turbo Power laser atherectomy + drug coated balloon (DCB) angioplasty for the treatment of femoropopliteal de novo/restenotic lesions and in-stent restenosis (ISR).

Key facts

Study ID

NCT03306199

Run by

Spectranetics Corporation

People needed

82

Starts

2017-10-03

Expected to finish

2018-06-05

Last updated by the study team

2019-04-08

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients treated for femoropopliteal de novo/restenotic lesions or in-stent restenosis using Turbo Power laser atherectomy plus drug coated balloon angioplasty

You may not qualify if…

• Any incomplete data on procedural approach and treatment

Where it is running

• Cardiovascular Institute of the South — Houma, Louisiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.